Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma

被引：0

作者：

Ly, Ina

Richardson, Leland

Liu, Mofei

Muzikansky, Alona

Lou, Kevin

Reardon, David A.

Arrillaga-Romany, Isabel

Forst, Deborah Anne

Jordan, Justin T.

Lee, Eudocia Quant

Dietrich, Jorg

Nayak, Lakshmi

Wen, Patrick Y.

Chukwueke, Ugonma Nnenna

Giobbie-Hurder, Anita

Choi, Bryan D.

Batchelor, Tracy

Kalpathy-Cramer, Jayashree

Curry, William T.

Gerstner, Elizabeth R.

机构：

[1] Massachusetts Gen Hosp, Boston, MA USA

[2] Harvard Med Sch, Dana Farber Canc Inst, Div Biostat, Dept Data Sci, Boston, MA USA

[3] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA

[4] Dana Farber Canc Inst, Boston, MA USA

[5] Harvard Med Sch, Boston, MA USA

[6] Harvard Med Sch, Dana Farber, Brigham & Womens Canc Ctr, Boston, MA USA

[7] Brigham & Womens Hosp, Boston, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2030

引用

页数：1